Immediate Impact
86 standout
Citing Papers
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
2024 Standout
Biomarkers for diagnosis and therapeutic options in hepatocellular carcinoma
2024 Standout
Works of Ayshea Hameeduddin being referenced
EASL and mRECIST responses are independent prognostic factors for survival in hepatocellular cancer patients treated with transarterial embolization
2011
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Ayshea Hameeduddin | 108 | 109 | 41 | 238 | 4 | 367 | |
| Yeh You Shen | 89 | 127 | 71 | 7 | 319 | ||
| Kristin La Fortune | 79 | 71 | 2 | 28 | 8 | 353 | |
| M Dufresne | 53 | 23 | 12 | 286 | 10 | 385 | |
| J.M. Corréas | 63 | 97 | 4 | 182 | 3 | 348 | |
| V. Wong | 62 | 19 | 1 | 170 | 10 | 370 | |
| Cody J. Boyce | 94 | 73 | 13 | 88 | 7 | 339 | |
| Yunbao Xia | 66 | 283 | 3 | 67 | 7 | 400 | |
| K S Naik | 100 | 116 | 2 | 144 | 9 | 318 | |
| Katrijn Michielsen | 62 | 180 | 3 | 44 | 7 | 400 | |
| Irene Tosetti | 163 | 53 | 7 | 79 | 10 | 357 |
All Works
Loading papers...